These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19753485)

  • 1. Perspectives of vaccination in Chagas disease revisited.
    Camargo EP
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():275-80. PubMed ID: 19753485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
    Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
    Front Immunol; 2020; 11():565142. PubMed ID: 33162979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biolistic DNA vaccination against Trypanosoma infection.
    Bryan M; Guyach S; Norris KA
    Methods Mol Biol; 2013; 940():305-15. PubMed ID: 23104351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
    Seid CA; Jones KM; Pollet J; Keegan B; Hudspeth E; Hammond M; Wei J; McAtee CP; Versteeg L; Gutierrez A; Liu Z; Zhan B; Respress JL; Strych U; Bottazzi ME; Hotez PJ
    Hum Vaccin Immunother; 2017 Mar; 13(3):621-633. PubMed ID: 27737611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
    Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
    Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
    Martinez-Campos V; Martinez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Seid CA; Hudspeth EM; Wei J; Liu Z; Kwityn C; Hammond M; Ortega-López J; Zhan B; Hotez PJ; Bottazzi ME; Dumonteil E
    Vaccine; 2015 Aug; 33(36):4505-12. PubMed ID: 26192358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.
    Sánchez-Valdéz FJ; Pérez Brandán C; Ferreira A; Basombrío MÁ
    Expert Rev Vaccines; 2015 May; 14(5):681-97. PubMed ID: 25496192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Chagas disease: can prophylaxis and therapeutic vaccines crack this 'hard nut'?
    Bontempi I; Vicco MH; Bayry J
    Immunotherapy; 2016 Feb; 8(2):99-101. PubMed ID: 26787323
    [No Abstract]   [Full Text] [Related]  

  • 9. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.
    Barry MA; Wang Q; Jones KM; Heffernan MJ; Buhaya MH; Beaumier CM; Keegan BP; Zhan B; Dumonteil E; Bottazzi ME; Hotez PJ
    Hum Vaccin Immunother; 2016 Apr; 12(4):976-87. PubMed ID: 26890466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi.
    Quijano-Hernández IA; Castro-Barcena A; Vázquez-Chagoyán JC; Bolio-González ME; Ortega-López J; Dumonteil E
    Vaccine; 2013 Apr; 31(18):2246-52. PubMed ID: 23499599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
    Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects of defined proteins for vaccine development.
    Frasch AC; Sánchez DO; Cazzulo JJ
    Mem Inst Oswaldo Cruz; 1990; 85(4):523-9. PubMed ID: 2152211
    [No Abstract]   [Full Text] [Related]  

  • 13. A therapeutic preconceptional vaccine against Chagas disease: A novel indication that could reduce congenital transmission and accelerate vaccine development.
    Dumonteil E; Herrera C; Buekens P
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006985. PubMed ID: 30703092
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic and therapeutic DNA vaccines against Chagas disease.
    Arce-Fonseca M; Rios-Castro M; Carrillo-Sánchez Sdel C; Martínez-Cruz M; Rodríguez-Morales O
    Parasit Vectors; 2015 Feb; 8():121. PubMed ID: 25885641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity and vaccine development efforts against Trypanosoma cruzi.
    Rios LE; Vázquez-Chagoyán JC; Pacheco AO; Zago MP; Garg NJ
    Acta Trop; 2019 Dec; 200():105168. PubMed ID: 31513763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control.
    Bivona AE; Alberti AS; Cerny N; Trinitario SN; Malchiodi EL
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165658. PubMed ID: 31904415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine development against Trypanosoma cruzi and Chagas disease.
    Vázquez-Chagoyán JC; Gupta S; Garg NJ
    Adv Parasitol; 2011; 75():121-46. PubMed ID: 21820554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neglected tropical diseases, bioinformatics, and vaccines.
    Rodrigues MM; Ersching J
    J Infect Dis; 2015 Jan; 211(2):175-7. PubMed ID: 25070940
    [No Abstract]   [Full Text] [Related]  

  • 20. A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection.
    Matos MN; Sánchez Alberti A; Morales C; Cazorla SI; Malchiodi EL
    Vaccine; 2016 Jun; 34(28):3243-51. PubMed ID: 27177947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.